Similarly, Interleukin 33 (IL-33) is secreted by CAFs during tumor progression but has also been found to enhance HNSCC invasion through MMP2/9 mediated ECM degradation [55]. This evidence concerns the gene MMP2 and head and neck squamous cell carcinoma.